| Financial Year |
March 31 2022 |
| Monetary Funds |
13,536,945,544.03 |
| Held-for-trading Financial Assets |
1,208,704,423.68 |
| Notes Receivable |
144,673,478.87 |
| Accounts Receivable |
35,068,604,824.77 |
| Advances to Suppliers |
3,209,433,655.07 |
| Other Receivables |
3,787,624,517.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
15,050,074,261.07 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
251,300,637.39 |
| Other Current Assets |
204,065,868.92 |
| Total Current Assets |
73,551,167,003.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,525,611,691.98 |
| Investment Properties |
541,941,104.93 |
| Fixed Assetes |
6,775,992,888.21 |
| Under-construction Projects |
1,567,385,735.73 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,155,877,430.54 |
| R&D expenses |
111,515,396.31 |
| Goodwill |
578,807,251.90 |
| Long-Term Deferred and Prepaid Expenses |
114,493,197.02 |
| Deferred Income Tax Assets |
336,301,660.68 |
| Other Non-Current Assets |
45,071,935.69 |
| Sub-Total of Non-Current Assets |
15,123,397,550.55 |
| Total Assets |
88,674,564,554.33 |
| Short-Term Loans |
13,043,796,199.84 |
| Trading Financial liabilities |
249,645,470.30 |
| Notes Payable |
22,188,958,166.39 |
| Accounts Payable |
15,082,046,102.62 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
217,634,911.22 |
| Taxes Payable |
427,819,161.57 |
| Interest Payable |
-- |
| Dividend Payable |
10,746,999.47 |
| Other payables |
4,305,118,489.47 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
235,452,167.83 |
| Other Current Liabilities |
607,300,572.82 |
| Sub-Total of Current Liabilities |
57,241,282,804.00 |
| Long-term Loans |
2,810,126,313.01 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
517,430,718.28 |
| Other Non-Current Liabilities |
68,540,200.00 |
| Sub-Total of Non-Current Liabilities |
3,875,193,587.86 |
| Total Liabilities |
61,116,476,391.86 |
| Paid-In Capital(Or Share Stock) |
1,873,869,441.00 |
| Capital Surplus |
8,251,343,628.31 |
| Surplus Reserve |
976,306,749.73 |
| LESS:Treasury Stock |
614,817,661.72 |
| Undistributed Profits |
11,022,454,457.29 |
| Minority Stockholder's Interest |
3,721,748,654.13 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
23,836,339,508.34 |
| Owner's Equity（Stockholder's Equity） |
27,558,088,162.47 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
88,674,564,554.33 |
